These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3193403)

  • 1. Apparent competitive inhibition of radioligand binding to receptors: experimental and theoretical considerations in the analysis of equilibrium binding data.
    Tomlinson G; Hnatowich MR
    J Recept Res; 1988; 8(6):809-30. PubMed ID: 3193403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental design and estimation of parameters in complex radioligand binding systems.
    Staschen CM; Homer LD
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):589-609. PubMed ID: 9300352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equilibrium competition binding assay: inhibition mechanism from a single dose response.
    Huang X
    J Theor Biol; 2003 Dec; 225(3):369-76. PubMed ID: 14604589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetics of competitive radioligand binding predicted by the law of mass action.
    Motulsky HJ; Mahan LC
    Mol Pharmacol; 1984 Jan; 25(1):1-9. PubMed ID: 6708928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer and competitive allosteric modulation model for G-protein-coupled receptors.
    Pietra D; Borghini A; Breschi MC; Bianucci AM
    J Theor Biol; 2010 Dec; 267(4):663-75. PubMed ID: 20800599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.
    Goldstein A; Barrett RW
    Mol Pharmacol; 1987 Jun; 31(6):603-9. PubMed ID: 3600604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioligand Binding Assays for Determining Dissociation Constants of Phytohormone Receptors.
    Hellmuth A; Calderón Villalobos LI
    Methods Mol Biol; 2016; 1450():23-34. PubMed ID: 27424743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological basis of receptor binding.
    Schütz W
    Wien Klin Wochenschr; 1991; 103(15):438-42. PubMed ID: 1656614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPCR-radioligand binding assays.
    Flanagan CA
    Methods Cell Biol; 2016; 132():191-215. PubMed ID: 26928545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for dissecting two site receptor interactions in ligand binding studies.
    Richardson A; Howlett DR
    J Recept Res; 1983; 3(4):541-60. PubMed ID: 6315934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand binding assays at equilibrium: validation and interpretation.
    Hulme EC; Trevethick MA
    Br J Pharmacol; 2010 Nov; 161(6):1219-37. PubMed ID: 20132208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites?
    Swillens S; Waelbroeck M; Champeil P
    Trends Pharmacol Sci; 1995 May; 16(5):151-5. PubMed ID: 7624969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions?
    Wittmann HJ; Strasser A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):595-612. PubMed ID: 28220211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
    Armstrong RA; Humphrey PP; Lumley P
    Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
    Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
    J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple.
    Krohn KA; Link JM
    Nucl Med Biol; 2003 Nov; 30(8):819-26. PubMed ID: 14698785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Displacement analysis of binding inhomogeneities in crude extracts of receptors.
    Batke J; Gaál J
    J Biochem Biophys Methods; 1986 Apr; 12(4):203-12. PubMed ID: 3011880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-binding studies: old beliefs and new strategies.
    Rovati GE
    Trends Pharmacol Sci; 1998 Sep; 19(9):365-9. PubMed ID: 9786024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive binding activity of angiotensin II analogues in an adrenal cortex radioligand-receptor assay;
    Saltman S; Baukal A; Waters S; Bumpus FM; Catt KJ
    Endocrinology; 1975 Aug; 97(2):275-82. PubMed ID: 169121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological analysis of CCK(2) receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK(2) receptor.
    Nilsson I; Monstein HJ; Lindström E; Håkanson R; Svensson S
    Regul Pept; 2002 Jan; 103(1):29-37. PubMed ID: 11738246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.